Literature DB >> 20426904

The origin of genetic risk for nasopharyngeal carcinoma:a commentary on: is nasopharyngeal cancer really a "Cantonese cancer"?

Malcolm J Simons1.   

Abstract

Entities:  

Mesh:

Year:  2010        PMID: 20426904     DOI: 10.5732/cjc.010.10070

Source DB:  PubMed          Journal:  Chin J Cancer        ISSN: 1944-446X


× No keyword cloud information.
  6 in total

1.  Prognostic value of 18F-fluorodeoxyglucose PET parameters and inflammation in patients with nasopharyngeal carcinoma.

Authors:  Liting Zhong; Chunming Li; Yunyan Ren; Dehua Wu
Journal:  Oncol Lett       Date:  2017-08-24       Impact factor: 2.967

2.  Nasopharyngeal carcinoma as a paradigm of cancer genetics.

Authors:  Malcolm J Simons
Journal:  Chin J Cancer       Date:  2011-02

3.  Establishment and Validation of a Nomogram for Nasopharyngeal Carcinoma Patients Concerning the Prognostic Effect of Parotid Lymph Node Metastases.

Authors:  Chao Lin; Xue-Song Sun; Sai-Lan Liu; Xiao-Yun Li; Nian Lu; Xin-Ling Li; Lin-Quan Tang; Ling Guo
Journal:  Cancer Res Treat       Date:  2020-03-10       Impact factor: 4.679

4.  LMP1-positive extracellular vesicles promote radioresistance in nasopharyngeal carcinoma cells through P38 MAPK signaling.

Authors:  Zhibao Zhang; Xuehui Yu; Zhuan Zhou; Bo Li; Jinwu Peng; Xia Wu; Xiangjian Luo; Lifang Yang
Journal:  Cancer Med       Date:  2019-08-22       Impact factor: 4.452

5.  A Nomogram to Predict Critical Weight Loss in Patients with Nasopharyngeal Carcinoma During (Chemo) Radiotherapy.

Authors:  Chen Huang; Hongxiu Chen; Xiaoxia Zhang; Qin Zhang; Juan Liu; Huaqin Yu; Yinbo He; Zhe Liu
Journal:  Clin Med Insights Oncol       Date:  2022-06-20

6.  Optimal cumulative cisplatin dose in nasopharyngeal carcinoma patients based on plasma Epstein-Barr virus DNA level after induction chemotherapy.

Authors:  Sai-Lan Liu; Xue-Song Sun; Li-Ting Liu; Rui Sun; Dong-Hua Luo; Qiu-Yan Chen; Huan-Xin Lin; Li Yuan; Lin-Quan Tang; Ling Guo; Hai-Qiang Mai
Journal:  Aging (Albany NY)       Date:  2020-03-27       Impact factor: 5.682

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.